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In cows, colostrum is composed of several antibodies and nutrients to provide immunity 
and energy to the calf. Feeding calves high quality colostrum has been shown to improve calf 
health, leading to reduced mortality in calves and greater milk production in cows. The addition 
of direct-fed microbials (DFM) to cow diets has been theorized to improve feed efficiency and 
milk production, with studies showing mixed results. However, few experiments have studied 
the effect of feeding DFM on colostrum quality. In this experiment two treatments were given, 1) 
DFM and 2) DFM and enzymes (DFME). Colostrum was analyzed to determine if yield, 
composition, and immunoglobulin (IgG and IgA) concentration were affected. Calf serum IgG 
and IgA concentrations were analyzed to determine if 24 h concentrations and apparent 
efficiency of absorption (AEA) were affected. There were no differences with regard to yield or 
IgA concentration. The percent of ash showed a positive trend, indicating a higher percentage 
with the treatments (P = 0.067).  The treatments had no effect on the additional components 
analyzed. The results for the IgG concentration were not significant although an increase was 
observed from 79.1 mg/mL in the control to 91.1 mg/mL in the DFME treatment. Neither 
treatment had an effect on calf immunoglobulin concentration or AEA. Based on the results, 
feeding DFM or DFME improves percent ash and might increase IgG concentration, but further 








 Colostrum is produced by mothers to be the first source of food a newborn will ingest. 
The concentrations of nutrients such as protein, fat, and carbohydrate vary greatly between 
species but are genetically controlled to provide suitable amounts for the survival of offspring 
(Langer, 2009). In general, fat and carbohydrates are metabolized for energy while proteins aid 
in cellular function or protect against pathogens as antibodies. Colostrum is initially synthesized 
in the weeks just prior to birth and stored in the developing mammary glands. After birth, 
colostrum will gradually transition to milk over hours or days, depending on the species.  
In cows, colostrum is analyzed for a variety of nutrients. The most common 
measurements are percent and yield of: fat, true protein (TP), total solids (TS), ash, and lactose. 
Compared to milk, colostrum contains less lactose but higher amounts of all other nutrients, most 
notably TP (Parrish et al., 1950). True protein consists only of proteins, rather than non-protein 
nitrogen sources; in colostrum, TP is composed mainly of casein and immunoglobulins. 
Immunoglobulins distinguish colostrum from milk, with significantly higher amounts of IgG, 
specifically IgG1, in addition to relatively smaller amounts of IgA and IgM (Kehoe et al., 2007).  
 The effect of colostrum intake in neonates has been studied across multiple species. 
Studies on neonatal puppies and kittens have found inadequate colostrum intake leads to failure 
of passive immune transfer (FPT; Claus et al., 2006; Mila et al., 2014). Similar results have been 
shown in neonates born agammaglobulinemic, including piglets and calves, where colostrum is 
the only source of functional immunoglobulins, including the primary immunoglobulin, IgG 
(Tyler et al., 1998; Rook and Bland, 2002). Failure of passive immune transfer, where serum 
antibody concentrations in the neonate are below experimentally derived levels, leaves the 
neonate without adequate protection against infections. Puppies (Mila et al., 2014) and calves 
(Tyler et al., 1998) with FPT had a greater risk of mortality than those with successful transfer. 
Besides mortality, there is evidence that dairy calves with FPT may have stunted growth rates as 
heifers (Robison et al., 1988) and lower milk production for 1st lactations (DeNise et al., 1989). 
Thus, colostrum has a considerable influence on the health and future productivity of the 
neonate.  
 In order to improve passive transfer rates, several approaches have been studied. The 
timing of colostrum feeding prior to gut closure is generally accepted as the greatest source of 
passive immunity in ungulates. Calves fed colostrum 6 h after birth had significantly higher 
serum immunoglobulin concentrations than those first fed 24 h or later, at which point gut 
closure occurs and the majority of colostral immunoglobulins are lost in feces (Matte et al., 
1982). However, the quality of colostrum ingested must also be considered. Nocek et al. (1984) 
found calves fed high quality colostrum, with over 60 mg/mL IgG, had greater weight gain and 
improved health compared to calves fed lower quality colostrum. A similar study on goat kids 
found higher concentrations of immunoglobulins in atomized colostrum paste caused increased 
absorption and serum immunoglobulin levels (Rodríguez et al., 2009). With a higher 
concentration of immunoglobulins, neonates are more likely to absorb greater amounts. 
Improving colostrum quality, with respect to component and immunoglobulin 
concentration, may be accomplished through the addition of direct-fed microbials (DFM) to 
maternal diets. Direct-fed microbials are live cultures of microorganisms chosen to improve the 
digestion, performance, and immunity of animals (McAllister et al., 2011). Some DFM affect the 
availability of nutrients to the animal. For example, the use of yeast, Saccharomyces cerevisiae, 
may improve fiber digestion by maintaining more desirable pH levels (Nocek et al., 2002; 
McAllister et al., 2011). With more nutrients available, animals can divert excess nutrients to 
production rather than maintenance. Other microbes may serve to upregulate the immune system. 
While several DFM compete with pathogenic bacteria in the digestive tract, others stimulate an 
immune response (McAllister et al., 2011). Further, some DFM products contain bacteria that 
produce enzymes (DFME) to enhance digestion of starch and cellulose. However, most studies 
feeding DFM to prepartum cows have focused on the nutrition and health of the dam and her 
milk production postpartum, rather than the impact to colostrum and calf health (Nocek and 
Kautz, 2006; Oetzel et al., 2007; Boyd et al., 2011; AlZahal et al., 2014). To fully understand the 
action of DFM, all aspects must be considered, including any benefits to the calves through 
colostrum. 
To determine if DFM has an impact on colostrum or calf health, two hypotheses were 
proposed. The first concerned colostrum. Not only have DFM had a positive impact on nutrition, 
but the microbes may increase immunoglobulin production. Studies in piglets have shown that 
feeding of DFM containing strains of Enterococcus faecium (Szabo et al., 2009) or S. cerevisiae 
with Pediococcus acidilactici (Lessard et al., 2009) increase pathogen-specific IgA 
concentrations. We hypothesized that feeding DFM or DFME would increase colostrum quality 
compared to cows fed a prepartum diet alone. Thus, higher concentrations of IgG, the major 
immunoglobulin in cow colostrum, and IgA should be seen in the colostrum of treated cows. 
Further, if DFM improve nutrition, higher amounts of colostral components were expected in 
treated cows.  
 The effective absorption of immunoglobulins by calves is the ultimate goal of higher 
quality colostrum. Calves fed maternal colostrum from DFM or DFME treated cows should 
ingest colostrum with greater concentrations of IgG and IgA. Thus, calves from DFM treated 
dams were expected to have higher serum Ig concentrations than calves from dams fed the 
prepartum diet only. In addition, if DFM affect colostral components regulating absorption, 
higher serum concentrations should be seen due to an increase in apparent efficiency of 
absorption (AEA) in the calves.  
 
Materials and Methods: 
 
 Thirty six multiparous Holstein cows housed at the UNH Fairchild Dairy Teaching and 
Research Center were studied. Cows were placed in one of 12 blocks based on expected calving 
date. Within a block, each cow was randomly assigned one of three treatments: 1) control (C), 
designated pre-partum diet only; 2) DFM only (T), designated pre-partum diet with 27.24 g/d of 
Tri-Lution®; or 3) DFM and enzyme (T+Z), designated pre-partum diet with 27.24 g/d of Tri-
Lution® and 18.16 g/d of Zy-mendTM. Tri-Lution® contains approximately 1.3 × 1012 cfu/kg of 
both Enterococcus faecium and Saccharomyces cerevisiae. Zy-mendTM is composed of 
approximately 9 × 1011 cfu/kg of E. faecium and S. cerevisiae, in addition to 4.4 × 106 cfu/kg 
Bacillus subtilis and 4.4 × 105 cfu/kg Trichoderma longibrachiatum. Cows began the study 21 d 
prior to their expected calving date. Each was kept in a tie stall bedded with mattresses and kiln-
dried sawdust from the start of the study until 3 d prior to the expected calving date, at which 
point they were moved to a maternity pen. Cows were fed separately in wooden tubs in tie stalls 
and metal tubs in maternity pens. Each cow had unlimited access to automated water bowls. One 
cow on the DFME treatment aborted and was removed from the study. In addition, one cow on 
the DFME treatment was fed the DFM treatment instead. 
 After calving, calves were removed as soon as possible to prevent nursing and dams were 
milked within 60 min to collect colostrum. The colostrum was weighed and analyzed for quality 
using either a colostrometer (Precision Hydrometer; Biogenics; Mapleton, OR) or refractometer 
(Sugar/Brix Refractometer 300001; SPER Scientific; Scottsdale, AZ). Two 40 mL samples were 
taken for further analysis. One was stored at -20°C for IgG and IgA radial immunodiffusion 
(RID) analysis (Triple J Farms, Bellingham, WA). The second was preserved with 2-bromo-2-
nitropropane-1,3-diol and shipped to DairyOne Cooperative, Inc. (Ithaca, NY) for analysis of fat 
(method 989.05, AOAC 2006), TP (method 991.20, AOAC, 2006), TS (method 990.20, AOAC, 
2006), ash (method 942.05) and lactose (calculated by the following equation: % TS - % fat - % 
TP - % ash). Two to 4 L of the remaining maternal colostrum was fed to the calf or calves within 
the first 2 h after birth. 
Calves: 
 After being removed, calves were weighed using a platform scale (Salter Scales, 
Fairfield, NJ). Each was then placed in a separate 1 × 2.15 m stall with a mat and kiln-dried 
sawdust. All were navel dipped with 7% iodine, and heifer calves received required Bovine 
Rota-Coronavirus (Calf Guard; Zoetis Inc.; Kalamazoo, MI) and Escherichia coli vaccinations 
(Bar-Guard-99; Boehringer Ingelheim; St. Joseph, MO). Blood samples at 0 h and 24 h were 
taken from the jugular vein using 22 gauge needles and 10 mL vacutainer tubes (Covidien, LLC, 
Mansfield, MA). Samples were then clotted and centrifuged at 4º C for 20 min at 4,261×  g 
(5430 R Eppendorf, Hauppauge, NY), 2,323×  g (5810R, Eppendorf, Hauppauge, NY) or 
1,704×  g (Servall Lynx 4000, Thermo Fisher Scientific, Chelmsford, MA). The serum was 
frozen at -20º C until IgG and IgA RID assays were performed (Triple J Farms, Bellingham, 
WA). 
 After the 0 h blood sample was collected, each calf was fed 4 L of colostrum via bottle or 
stomach tube. 10 calves did not receive the full 4 L of maternal colostrum. Six of these 10 calves 
had trouble bottle feeding and stomach tubing the full amount. The other four calves did not 
receive enough because their dam produced less than 4 L of colostrum. In addition, 3 calves 
received no maternal colostrum due to the dam being leukosis positive; these 3 calves did not 
have blood samples taken at 24 h as they were fed either frozen colostrum from the farm and/or 
colostrum replacer. 
Radial Immunodiffusion for IgG and IgA: 
 Plates were obtained for RID analysis of the IgG and IgA concentrations in colostrum 
and calf serum. Distilled water and three standards (IgA: 53, 194, 387 mg/dL; IgG: 196, 1402, 
2748 mg/dL) were used to determine the concentration. For the colostrum samples, samples were 
thawed and mixed prior to pipetting. Colostrum samples were diluted with distilled water 1:4 for 
IgG and 1:3 for IgA. Five µL of each sample was pipetted into the corresponding well, with two 
samples per cow to be averaged. For blood serum samples, samples were thawed and mixed 
prior to pipetting. Serum was directly pipetted into the corresponding well, with 2 samples per 
calf to be averaged. All plates were left at room temperature in the resealed packages for 48 h. 
After 48 h, plates were read using a digital RID plate reader (Binding Site, Birmingham, UK). 
Standards were graphed and the averaged sample diameters compared with the graph to 
determine concentrations. Samples were rerun if the diameters of the two samples from the same 
animal differed by 10mm or greater. Samples with diameters greater than the largest standard 
were rerun at a higher dilution. 
Statistical Analysis: 
 Data was analyzed using the MIXED procedure in SAS (SAS 9.4, Cary, NC.) Means for 
each treatment and standard errors were reported. Parity was used as a covariate for calf 
immunoglobulin concentration at 24 h and AEA. The covariate was removed from the model if  
P ˃ 0.25. Significance was defined as P ≤ 0.05. Trends were defined as 0.05 ˂ P ≤ 0.1.  
Results: 
 
 For colostrum, there were few differences between treatments. Cows on the control diet 
with no DFM had the highest yield (10.7 ± 1.49 kg) while the DFM treatment of Tri-Lution® 
only had the lowest (6.56 ± 1.45 kg); however, there was no difference (P ˃ 0.05) in yield 
between any treatments (Table 1). Cows fed DFME had the highest concentrations of IgG and 
IgA in colostrum compared to the other treatments, but again were not significantly higher (P ˃ 
0.05). Although cows in the control group produced colostrum with the lowest concentration of 
IgG (79.1 ± 5.54 mg/mL), those cows also yielded the most IgG of all treatments 
(836.8 ± 105.9 g). IgG concentrations for all treatment groups ranged from 46.7 to 134.2 
mg/mL. 
Table 1. Descriptive statistics of treatments for colostrum yield, immunoglobulin concentration, 
and colostrum composition in cows fed control, DFM, or DFME treatments 21 d prior to 
expected parturition. 
 Treatment1  
 C  T  T + Z   
Variable Mean  Mean  Mean SE P value 
Colostrum  (kg) 10.7  6.56  9.40 1.6 0.159 
IgG (mg/mL) 79.1  88.2  91.1 6.0 0.338 
IgG (g) 836.8  562.0  782.3 116.5 0.186 
IgA (mg/mL) 6.30  6.07  6.97 0.6 0.475 
IgA (g) 63.31  37.22  62.83 8.8 0.054 
Fat (%) 5.76  5.14  4.90 0.9 0.752 
Fat (kg) 0.66  0.37  0.52 0.13 0.237 
TP (%) 13.7  16.1  16.1 1.0 0.134 
TP (kg) 1.42  1.06  1.33 0.2 0.408 
TS (%) 26.0  25.3  24.9 2.2 0.931 
TS (kg) 2.72  1.70  2.20 0.4 0.128 
Ash (%) 1.07  1.16  1.25 0.05 0.067 
Ash (kg) 0.11  0.06  0.08 0.02 0.245 
Lactose (%) 5.48  2.85  2.58 1.6 0.352 
Lactose (kg) 0.47  0.19  0.26 0.12 0.181 
 




Figure 1: Colostral IgA yield for control (C), DFM (T) and DFME (T+Z) treatments, 
P = 0.054. 
 
 
There was a trend in IgA yield (P = 0.054). The amount of IgA in the DFM only 
treatment was lower (37.22 ± 7.69 g) than either the control or DFME treatments (63.31 ± 8.13; 
62.83 ± 8.84 g, respectively) (Fig. 1). There was no effect on the concentration of IgA in 




































Figure 2: Percentage of true protein (TP) in colostrum for control (C), DFM (T) and DFME 
(T+Z) treatments, P ˃ 0.05. 
 
The treatments also had few effects on the composition of components in colostrum. 
There was no significant effect of DFM or DFME on yield or percentage for all colostral 
components measured.  Cows in the control group produced higher percentages of fat, TS, and 
lactose than DFM treated cows, with DFME cows producing colostrum with the lowest 
percentage of these components (Table 1). Although not different (P = 0.13), percent of TP in 
colostrum from DFM and DFME treated cows was greater (16.1%) than in control cows (13.7%) 

























Figure 3: Percentage of ash in colostrum for control (C), DFM (T) and DFME (T+Z) treatments, 
P = 0.067. 
 
In addition, there was one trend (P = 0.067) regarding ash percent. Cows fed DFME 
showed a positive increase in ash percentage (1.25 ± 0.05%), followed by DFM treatment (1.16 





































 For calves, there was no difference between treatments. Calf body weight (BW) at birth 
was not affected by DFM treatment (Table 2). Most calves started with no serum IgG or IgA at  
0 h, although 9/37calves had negligible amounts of IgG present (Fig. 4 and 5). Calves absorbed 
both IgG and IgA; however, there was no difference in serum concentrations at 24 h or AEA 
between control and treatment groups. Serum IgG concentrations at 24 h for all treatment groups 
ranged from 12.8 to 42.7 mg/mL. 
 
 
Table 2. Descriptive statistics of calf body weight at birth, serum immunoglobulin 
concentrations, and apparent efficiency of absorption after ingestion of maternal colostrum. 
  
 Treatment1  
 C  T  T + Z   
Variable Mean  Mean  Mean SE P value 
BW (kg) 44.1  44.7  45.8 2.0 0.826 
IgG 0 h (mg/mL) 1.7  0.3  1.2 1.0 0.575 
IgG 24 h (mg/mL) 24.6  25.9  26.3 3.4 0.920 
IgA 0 h (mg/mL) 0.03  0.00  0.00 0.02 0.442 
IgA 24 h (mg/mL) 1.43  1.54  1.49 0.15 0.509 
AEA IgG2 (%) 34.1  31.1  33.5 3.4 0.800 
AEA IgA3 (%) 29.3  28.1  29.5 2.9 0.928 
        
1Treatment: C = No Tri-Lution® or Zy-MendTM; T = 27.24 g/d Tri-Lution®; T + Z = 27.24 g/d Tri-Lution® and 18.16 
g/d Zy-MendTM. 
2AEA IgG: ((Serum IgG [g/L] * BW[kg]*0.09)/IgG Intake[g])*100 














Figure 4: Serum IgG concentration in calves at 0 h and 24 h after birth. Calves were grouped as 
control (C), DFM (T) or DFME (T+Z) based on the treatment group of the dam. P ˃ 0.05 for 





Figure 5: Serum IgA concentration in calves at 0 h and 24 h after birth. Calves were grouped as 
control (C), DFM (T) or DFME (T+Z) based on the treatment group of the dam. P ˃ 0.05 for 
















































 The addition of DFM or DFME to prepartum cow diets had few effects on the quality or 
composition of colostrum. Similarly, there was no difference with regard to the calf variables 
measured. 
Considering colostrum yield, there was no difference between treatments, although cows 
in the control group produced more than either treatment group. There is a lack of data on the 
effect of DFM on colostrum yield as the majority of studies have focused on milk yield. Previous 
studies have shown mixed results regarding milk yield after treatment with DFM, with some 
reporting improved yields (Nocek and Kautz, 2006; Boyd et al., 2011) while others showed no 
difference (Oetzel et al., 2007; AlZahal et al., 2014). Caution must be used comparing milk to 
colostrum, however, as milk yields may not predict colostrum yields (Cabral et al., 2016).  
The concentration of either IgG or IgA was not affected by treatment. For yield, cows on 
the DFM treatment produced the least immunoglobulin, specifically IgA. This most likely 
reflects their lower colostrum yield, as all groups had similar immunoglobulin concentrations. 
The concentration of IgG is comparable to the average of 74.2 mg/mL for colostrum from 
Holsteins (Morrill et al., 2012). Few studies in cattle have been conducted to determine if 
immunoglobulin concentrations are affected by DFM. One DFM study using Angus-cross steers 
challenged with E. coli O157:H7 found no change in serum or fecal concentration of either IgG 
or IgA, although levels in the DFM group tended to be higher (Guillen, 2009). Guillen (2009) 
noted that granulocyte levels were significantly higher with DFM treatment, in addition to other 
indications of an increased immune response. Another study in day-old chicks found increased 
levels of IgG and IgA in serum and intestinal secretions with DFM treatment; although several 
mechanisms were proposed, none could be determined as causing the increase (Haghighi et al., 
2006). While the mechanisms behind the proposed action of DFM on immunoglobulin 
production remains unclear, the DFM fed in this experiment did not affect the uptake of IgG or 
IgA by the mammary gland for colostrum. 
Besides the effect of DFM, colostrum quality can be affected by yield at first milking. 
Pritchett et al. (1991) described an inverse effect of first milking yield on IgG concentration, 
where yields greater than 8.5 kg began showing dilution of IgG. In contrast, this experiment 
found no negative impact, as both control and DFME groups had high quality colostrum with 
yields over 8.5 kg (Table 1). 
Although not significant, there was an increase in percentage of TP with the DFM 
treatments. For Holsteins, the average percentage of colostral protein is 12.5%, which is close to 
the control group but noticeably lower than the DFM/DFME treatment groups (Morrill et al., 
2012). As the immunoglobulin concentrations were not affected by treatment, other proteins 
contributed to the increase. Oetzel et al. (2007) found an increase in milk protein percentage 
during the early stage of lactation feeding two strains of E. faecium and S. cerevisiae. In contrast, 
Nocek and Kautz (2006) found no difference in milk protein percentage feeding E. faecium 
alone. For further study, TP should be analyzed further to determine which proteins may be 
increased with DFM supplementation. 
There was a trend regarding ash percentage. Groups fed DFM had the highest 
percentages, meaning the colostrum contained more minerals. Ash percentage values were 
similar to previous values for colostrum from Holsteins (Parrish et al, 1950; Oyeniyi and Hunter, 
1978). The various minerals, especially Ca and P, are vital to the proper growth and metabolism 
of calves. No previous DFM studies have analyzed colostrum or milk for ash content. Based on 
these results, DFM may improve bioavailability or uptake of minerals. Again, further analysis of 
the ash composition may reveal if DFM influence some or all minerals in colostrum. 
 While DFM had mixed results on colostrum quality, there was no effect seen in calves. 
Neither serum concentrations at 24 h after birth nor AEA differed between groups. The average 
calf in all groups absorbed acceptable levels of IgG, reaching a recommended concentration 
above 10 mg/mL (Quigley and Drewry, 1998). Several factors serve a role in absorption of 
immunoglobulins, such as age and colostrum quality (Quigley and Drewry, 1998). Regarding 
quality, Stott and Fellah (1983) found AEA increased with higher IgG concentration, resulting in 
less colostrum required for adequate absorption. As all groups had similar, high quality 
colostrum, it is unsurprising AEA and serum concentration were unaffected. If DFM cause an 
increase in proteins or compounds aiding immune function, as proposed, there does not appear to 
be an effect on calf gut absorption of immunoglobulins (McAllister et al., 2011). 
For future studies, more work should be devoted to improving colostrum, as there appear 
to be more possibilities for feeding of DFM. For example, individual cows may react differently 
to DFM. Nocek and Kautz (2006) found that cows supplemented with DFM had lower milk fat 
percentages than the control group. However, the researchers noted that DFM did not depress fat 
production and that cows in the treatment group tended to produce less fat based on their 
previous lactation (Nocek and Kautz, 2006). This difference may have accounted for differences 
between groups. Future experiments should consider following cows over two pregnancies, 
starting on either a control or DFM treatment diet and switching treatments between pregnancies 
to determine if DFM has an individual effect on colostrum quality. 
Another consideration is timing of DFM supplementation. In order to cause effects, the 
DFM must first colonize the rumen, which may not occur immediately. Notable increases in 
IgG1 in colostral secretions may begin as early as 5 wk prior to parturition, with most substantial 
colostrogenesis starting between 2 and 3 wk prior (Brandon et al., 1971). In this experiment, 
feeding of DFM did not begin until 3 wk prior to expected parturition, meaning that 
immunoglobulins already present were being sequestered in colostrum as DFM began colonizing 
the rumen. A longer period between the start of DFM treatment and parturition may allow 
additional effects to be seen. 
Finally, other DFM products should be studied, as Tri-Lution® and Zy-Mend
TM contain 
only four of hundreds of potential microbes. All have various modes of action; some may prove 
more effective at improving colostrum than others. As more than 60% of all colostrum produced 
in the United States is poor quality, below 50 mg of IgG/mL, any improvement is welcome to 
prevent development of FPT in calves (Morrill et al., 2012). Further studies must determine 




 Feeding DFM or DFME to prepartum cows improved ash percentages in colostrum. 
However, supplementation had no effect on the IgG or IgA concentration of colostrum, nor on 
the additional colostral components. Calf body weight, 0 and 24 h serum concentrations of IgG 
and IgA, and AEA of both immunoglobulins were not affected by DFM treatment, either prior to 
parturition or by feeding of maternal colostrum from DFM supplemented dams. Future studies 
must investigate the usefulness of feeding DFM for the purpose of improving colostrum by 
determining the mechanisms and best microbial species to feed. Understanding how DFM may 
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